SCHEMBL22179995

SCHEMBL22179995

Nc1nc(-c2ccc(F)cc2)cc(C2CC2)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.55
▸ ADORA2A P29274 3/20 0.52
▸ ADORA1 P30542 3/20 0.52
▸ DRD2 P14416 1/20 0.49
▸ DRD4 P21917 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ HRH4 Q9H3N8 1/20 0.42
▸ CYP1A1 P04798 1/20 0.42
▸ CYP1B1 Q16678 1/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ ALOX5 P09917 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CDK1 P06493 3/20 0.40
▸ CDK2 P24941 3/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3452347 0.86 KDM4E (0.70) KDM4EADORA2AADORA1CYP1A1CYP1B1
SCHEMBL5511069 0.77 KDM4E (0.64) KDM4EADORA2AADORA1CYP1A1CYP1B1
SCHEMBL6979605 0.74 DRD2 (0.59) KDM4EADORA2AADORA1DRD2DRD4
SCHEMBL1644353 0.74 HSP90AA1 (0.68) KDM4EADORA2AADORA1HRH4ALDH1A1
SCHEMBL3451384 0.74 KDM4E (0.60) KDM4EADORA2AADORA1CYP1A1CYP1B1
SCHEMBL13127057 0.74 KDM4E (0.60) KDM4EADORA2AADORA1ALDH1A1ALOX5
SCHEMBL6981381 0.73 HRH4 (0.62) KDM4EADORA2AADORA1DRD2DRD4
SCHEMBL21801523 0.71 KDM4E (0.57) KDM4EADORA2AADORA1HRH4CYP1A1
SCHEMBL6968638 0.71 KMT2A (0.57) KDM4EDRD2DRD4DRD3HRH4
SCHEMBL28462934 0.71 ADORA2A (0.53) KDM4EADORA2AADORA1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113166119-B Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2024-01-05 — — CN disclosed
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-12-23 — — US disclosed
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. (CN) 2021-12-23 — — US disclosed
EP-3904352-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) 2021-11-03 — — EP disclosed
CN-113166119-A Substituted aryl compound and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-07-23 — — CN disclosed
WO-2020135210-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2020-07-02 — — WO disclosed
WO-2020135210-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2020-07-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395226-A1 SUBSTITUTED ARYL COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF ADORA2A, ADORA1, ADORA3 KDM4E 4450/4885ADORA2A 1/4885ADORA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback